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The properties of mononuclear phagocytes are influenced by contact with surface- 
bound stimuli.  Spreading is greatly enhanced when the surface to which monocytes 
or macrophages  adhere  incorporates  immune complexes  (1,  2),  and  monocytes cul- 
tured  on surface-bound  IgG aggregates  undergo  a  respiratory  burst  that  generates 
superoxide anion and other oxygen products  (3). Monocyte neutral  protease activity 
also is greatly modified; granule-associated protease activity is elicited,  and secretion 
of plasminogen activator is inhibited by culture on surface-bound immune complexes 
(4). Immune complex-stimulated monocyte spreading can be inhibited by cytoskeletal 
disruption with colchicine or cytochalasin B and by membrane-active local anesthetics 
(5).  Superoxide anion generation and lysosomal enzyme release also can be inhibited 
by local anesthetics  (6,  7). 
Surface-bound immune complexes also affect the Fc receptor activity of mononu- 
clear phagocytes. Resident mouse peritoneal macrophages plated onto surface-bound 
immune complexes lose the capacity to phagocytose IgG-sensitized sheep erythrocytes 
(SRBC) 1 (EA) but not latex particles or zymosan (8).  Rosetting of such macrophages 
with EA is not affected, which suggests the maintenance of some Fc receptor function 
with  a  selective  inhibition  of receptor-triggered  interiorization.  In contrast,  human 
monocytes lose the ability to form EA rosettes  when  incubated  upon surface-bound 
immune  complexes  (2).  The  mechanism  of reduction  in  Fc  receptor  function  or 
number has not been elucidated;  it is not known whether Fc receptors are interiorized, 
capped, or whether their activity is altered by some other means. 
In this paper, we confirm that human peripheral blood monocytes lose EA rosetting 
ability when in contact with surface-bound immune complexes. Our results indicate 
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that  this  loss  is  not  a  result of Fc  receptor  migration or  interiorization and is  not 
mediated by cytoskeletal elements. Also, the loss does not result from damage of Fc 
receptors by lysosomal enzymes or oxygen radicals. We present data that suggest that 
after monocytes adhere to surface-bound immune complexes, Fc receptor activity is 
modulated by cyclic nucleotide-dependent mechanisms. 
Materials and Methods 
Materials.  Dulbecco's  Modified  Eagle's  Medium  (DME),  Hanks'  balanced salt  solution 
(HBSS),  and fetal calf serum (FCS)  were obtained from Grand Island Biological  Co.,  Grand 
Island, N. Y. Lactalbumin  hydrolysate (LH) was purchased from ICN Nutritional Biochemicals, 
Cleveland, Ohio. Bovine fibrinogen, superoxide dismutase (SOD), and human serum albumin 
(HSA)  were  obtained  from  Miles  Laboratories,  Inc.,  Elkhart,  Ind.  SRBC  hemolysin was 
purchased from N. L. Cappel Laboratories Inc., Cochranville, Pa. Catalase was purchased from 
Boehringer Mannheim Biochemicals, Indianapolis, Ind. Cytochalasin B,  acetaldehyde, and 
methyl isobutyl xanthine (MIBX) were obtained from Aldrich Chemical Co., Inc., Milwaukee, 
Wis.  Cycloheximide, colchicine,  D-e-propranolol, 8-bromoadenosine 3':5'-cyclic monophos- 
phoric acid (8 Br-cAMP), 8-bromoguanosine  3':5'-cyclic monophosphoric acid (8 Br-cGMP), 2- 
deoxy-D-glucose  (2dG),  and ATP were  purchased from Sigma Chemical Co., St.  Louis, Mo. 
Lidocaine was obtained from Astra Pharmaceutical Products, Inc., Worcester, Mass.,  and  1- 
octanol from  Mallinckrodt Inc., St.  Louis,  Mo.  Ficoll-Hypaque and Sephadex  G-200 were 
obtained from  Pharmacia  Fine Chemicals,  Inc.,  Piscataway,  N.  J.,  and  diethylaminoethyl 
cellulose  (DE-52)  from Whatman, Inc., Clifton, N. J. C5-deficient mice were kindly supplied 
by Dr. George Martin of the University of Washington, Seattle, Wash. 
Preparation ofMonolayers. Mononuclear leukocytes (MNL) were obtained by Ficoll-Hypaque 
centrifugation of EDTA-anticoagulated human blood. The cells were washed once in 0.005 M 
phosphate-buffered saline (PBS)  that contained 1 mM EDTA, and twice in HBSS, and then 
were suspended in DME with 0.05% lactalbumin hydrolysate (DME-LH). 
For immediate application to substrates, MNL were diluted to 0.8 ×  10  s cells/ml in DME- 
LH with or without drugs, and 2.5-ml aliquots were pipetted into 35-mm culture plates coated 
with fibrin or fibrin that contained adherent immune complexes.  The plates were incubated at 
37°C in a  5%  CO2  atmosphere for  1 h  and then vigorously washed  four times with warm 
HBSS. The medium was replaced before further incubation with reagents for determination of 
Fc or C3 receptor activity. In some experiments monolayers were cultured in DME with 10% 
FCS for 21 h. 
If prolonged preincubation with  drugs  was  required,  MNL  at  1.6  ×  106  cells/ml were 
incubated with the drug in a 37°C shaking water bath in 50-ml gassed, sealed culture tubes for 
30-180 min. At the end of the incubation period the cells were spun, resuspended in their 
original volume of DME-LH that contained the drug, and applied to substrates, as described 
above. Preincubation of MNL with some drugs reduced total adherence, but no drug reduced 
the percentage of adherent cells that were peroxidase positive. 
For some experiments, cell  monolayers were formed and then incubated with enzymes or 
drugs before  determination of Fc  receptor  activity. Superoxide anion  (02-)  and  hydrogen 
peroxide (H202)  were generated in the presence of adherent cells using xanthine oxidase with 
acetaldehyde as substrate (9). In other experiments, cell suspensions were cooled to 2-4°C on 
ice before application to substrates. For studies with macrophages, alveolar cells were obtained 
from rabbits after repeated intravenous administration of complete Freund's adjuvant (10). 85- 
90% of the alveolar cells appeared to be macrophages by Wright's stain examination and <5% 
were heterophiles. 
Preparation of Substrates. For preparation of culture plates, bovine fibrinogen was dissolved  in 
warm PBS, then diluted to 333/~g/ml with warm distilled water and filtered. 0.3-ml aliquots 
of the fibrinogen solution were applied to 35-mm culture plates and spread with a sterile glass 
rod.  Plates were  then dried at  45°C for  2 d.  (11). For preparation of plates that  contained 
surface-bound immune complexes, HSA as antigen was added to the bovine fibrinogen solution 
to give a  final HSA concentration of 8-660/zg/ml, to make plates with 2.5,  10, or 200/zg of 
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contained  10% FCS for 2 h at 37°C to convert the fibrinogen to fibrin, then were washed twice 
with HBSS. Immune complexes were prepared by incubating plates that contained fibrin-HSA 
with  1-ml vol of HBSS that  contained  10, 25,  100, or  1,000 p,g of monomeric rabbit  IgG anti- 
HSA.  Plates  were  incubated  for  15  min  at  room  temperature  and  then  washed  twice with 
HBSS. When fibrin plates that contained 2.5/~g HSA were incubated with  10, 25, and  100 #g 
of anti-HSA, 0.3, 0.5, and  1 btg, respectively, of antibody adhered  to the plates, as determined 
by control  experiments  using  1251-anti-HSA.  Plates  that  contained  10 /zg of HSA  incubated 
with  100/zg of anti-HSA had  2 #g of adherent  antibody,  and  plates that  contained  200 #g of 
antigen  incubated  with  1,000/zg  of antibody  contained  20 p,g of adherent  antibody.  Unless 
otherwise  indicated,  plates  prepared  with  immune  complexes  contained  2  /zg  of adherent 
antibody. 
Some plates containing standard  amounts of antibody were coated with C3 by incubation 
with 1 ml ofa 1:5 dilution of C5-deficient mouse serum in veronal buffer containing 1% gelatin 
(GVB)  for 30 min at 37°C, then washed twice. 
Rabbit  IgG anti-HSA was isolated from the serum of hyperimmunized  rabbits  by affinity 
chromatography and gel filtration (10). 
Coating of SRBC with IgG (EA) or with IgM and C3 (EAC). Rabbit IgG SRBC hemolysin was 
obtained  from  antiserum  by  ion-exchange  chromatography  on  DE-52  and  gel  filtration 
chromatography on G-200 and stored in PBS at 2.8 mg/ml. The IgM fraction was obtained by 
similar purification on DE-52 and Sephadex G-200 and stored in PBS at  1.45 mg/ml. 
SRBC were obtained  from a  single animal for all experiments, stored in Alsever's solution, 
and used within 2 wk. The SRBC were washed three times in GVB with aspiration of the buffy 
coat  after  each  wash,  then  suspended  in  GVB  at  109 cells/ml.  Antibody  preparations  were 
diluted  1:100  (IgG) and  1:300  (IgM)  in GVB to give maximal subagglutinating sensitization. 
Volumes of antibody were added dropwise with continuous mixing to equal volumes of SRBC 
and incubated  for 30 rain at 37°C in a  shaking water bath. The antibody-sensitized cells then 
were washed three times with cold GVB. EA were used at 5 ×  109 cells/ml. 
SRBC sensitized with IgM were suspended  at  2  X  l0  s cells/ml. C5-deficient mouse serum 
was diluted  1:5 and added dropwise to an equal volume of EAC. After 30 min of incubation at 
37°C in a shaking water bath, the EAC were washed three times, as above, and used at  1 X  l0  s 
cells/ml. 
Rosetting Assays. The medium was decanted  from culture plates and  1-ml vol of EA or EAC 
were pipetted into the plates. When monolayers had been pretreated with drugs, EA and EAC 
suspensions  were  made  up  both  with  and  without  drugs  to  control  for  drug  effects on  the 
indicator rather than  monolayer cells. No drug disrupted  rosettes.  Plate covers were taped  so 
that  the codes  of drug  treatment  and  substrate  would  not  be  known  during  the  reading  of 
rosettes. In most experiments, the sensitized SRBC were allowed to settle by gravity for 1 h at 
room temperature  (25°C). The plates then were slowly rocked to suspend unattached  erythro- 
cytes and gently washed three times. Duplicate plates were read by two observers, and 200 cells 
were  counted  per  plate.  Adherent  cells with  three  or  more  attached  SRBC  were  scored  as 
rosettes. The percentage of cells forming rosettes was expressed  as the mean of duplicates  in 
each experiment.  There was no advantage  in enumerating attached  erythrocytes over simply 
counting rosettes. No rosettes formed when monolayers were incubated with unsensitized SRBC 
or with IgM sensitized SRBC. 
In some experiments the EA rosetting temperature was 37°C and, after washing, some plates 
were exposed  to one-half strength  PBS for  10 s  to  lyse attached  EA.  Phagocytosed  EA then 
could be visualized; monocytes with one or more interiorized EA were scored as phagocytic. In 
other experiments the EA rosetting temperature was 2-4°C after formation of monolayers at 37 
or 4°C, as indicated in Results. 
Results 
Fc and C3 Receptor Activity of MNL Cultured on Surface-Bound Immune Complexes. 90% of 
MNL  adherent  to  fibrin  were monocytes  as  determined  by  peroxidase  staining  and 
latex  particle  adherence.  In  21  experiments,  87  +  10%  rosetted  with  EA;  and  in  6 
experiments,  89 +  8%  formed  EAC rosettes  (Table I). C.  G.  RAGSDALE  AND W.  P.  AREND 
TABLE  I 
Receptor Activity of Adherent MNL * 
35 
Substrate with surface-  Substrate without surface-  bound immune  Percentage of cells  bound immune complexes$  complexes:~ 
Peroxidase positive  89 --. 4  (4)  65 ztz 5 (4) 
Forming EA rosettes  87 +  10 (21)  9 +  7 (15) 
Forming EAC rosettes  89 ztz 8  (6)  70 +-- 8 (6) 
* Monolayers were prepared on fibrin substrates with or without surface-bound HSA-anti-HSA immune 
complexes, then stained for peroxidase or incubated with rosetting reagents as described in Materials and 
Methods. 
For each experiment, plates were prepared in duplicate, and 200 cells were counted per plate. The data 
are expressed as the mean percentage of cells --. 1 SD. The number of experiments is given in parentheses. 
About 65% of MNL adherent to surface-bound immune complexes were monocytes, 
but only 9  +_ 7% formed EA rosettes. This loss in EA rosetting was seen as early as 30 
min after plating of MNL onto complexes. Reduced rosetting persisted through 21  h 
of culture in  10%  FCS; during this time the cells also lost viability (4). When  plates 
were sensitized with F(ab')2 anti-HSA, 78% of the adherent cells formed EA rosettes. 
EAC rosettes were formed by 70 +  8% of MNL  adherent  to complexes (Table I). In 
one experiment, IgG-sensitized plates were  incubated  with  20%  C5-deficient  mouse 
serum in GVB, washed, and then MNL  were applied. C3 rosetting was not reduced. 
Thus, as has been observed by Douglas (2), MNL cultured on surface-bound immune 
complexes exhibited a  selective loss of EA rosetting. 
In one experiment, plates were prepared that contained immune complexes on one- 
half of the surface. MNL were allowed to settle on these plates and then EA rosetting 
was  measured.  92%  of MNL  adherent  to  the portion  of the plate without  immune 
complexes  formed  EA  rosettes,  but  only  7%  adherent  to  the  half that  contained 
immune  complexes formed  rosettes.  In addition, when  MNL  on  plain  fibrin plates 
were  incubated  with  soluble HSA-anti-HSA complexes  at  2-10  #g/ml  for  30  min, 
then  washed, and  then  incubated with  EA, 86%  formed rosettes. Therefore,  neither 
solubilized complexes nor soluble factors released by adherent cells accounted for the 
reduced EA rosetting of monocytes on surface-bound immune complexes. 
Effect of Differently  Sensitized Plates on Fc Receptor and Phagocytic Activity of Monocytes and 
Rabbit Alveolar Macrophages.  Rabinovitch et al.  (8)  observed that  unstimulated mouse 
peritoneal  macrophages  incubated  on  surface-bound  immune  complexes  displayed 
reduced  Fc-mediated  phagocytosis,  but  attachment  of  EA  was  not  altered.  We 
compared the abilities of human monoeytes and rabbit alveolar macrophages to form 
EA rosettes and to phagocytose antibody-coated SRBC using substrates that contained 
0.10-10 times the standard amounts of antibody (2 #g). Both attachment of EA and 
phagocytosis of the sensitized cells by human monocytes were reduced as the antibody 
density was increased from 0.3 to 2 #g per plate (Table II). There was no point where 
phagocytosis was  selectively lost.  A  slight  loss  of EA  rosetting  was  observed  when 
activated rabbit alveolar macrophages were in contact with plates that contained  2 
~tg  of antibody,  but  phagocytosis was  reduced  by  90%  (Table  III).  Although  EA 
rosetting could  be  further  reduced  with  a  more  heavily sensitized  plate  (20  /tg of 
antibody),  it  was  relatively better  preserved  with  the  rabbit  alveolar macrophages 
than with the human peripheral monocytes. 36  Fc  RECEPTOR  ACTIVITY  OF  HUMAN  MONOCYTES 
TABLE  II 
Effect of Substrate Sensitization on Fc Receptor and Phagocytic Activity of Human MNL* 
Antibody/plate 
Percentage of cells$ 
Forming EA rosettes  Phagocytosing sensitized 
SRBC 
/lg 
0  68  80 
0.3  45  49 
0.5  21  44 
1  8  16 
2  2  5 
* Monolayers were prepared on substrates that contained different amounts of immune complexes (as 
described in Materials and Methods), and then were incubated with EA for l h at 37°C. After washing, 
plates to be scored for phagocytosis were exposed for 10 s to half-normal PBS to lyse adherent, but not 
interiorized, SRBC. 
:~ Adherent cells with three or more SRBC attached were scored as rosettes and cells with one or more 
interiorized SRBC were scored as phagocytic. 
TABLE  III 
Effect of Substrate Sensitization on Fc Receptor and Phagocytic Activity of Rabbit Alveolar Macrophages* 
Antibody/plate 
Percentage of cells:~ 
Forming EA rosettes  Phagocytosing sensitized 
SRBC 
gg 
0  73  29 
2  46  3 
20  30  3 
* Macrophage  monolayers were  prepared  on  substrates that  contained different  amounts  of immune 
complexes (as described in Materials and Methods), and then were incubated with EA for 1 h at 37°C. 
After washing, plates to be scored for phagocytosis were exposed  for  10 s to half-normal PBS to lyse 
adherent, but not interiorized, SRBC. 
:~ Macrophages with three or more SRBC attached were scored as rosettes,  and cells with one or more 
interiorized SRBC were scored as phagocytic. 
Effect of Cold, Cytoskeletal  Disruption, and Propranolol on Fc Receptor Activities.  Monocytes 
and  macrophages  have  been  observed  to  cap  EA  (12)  and  cross-linked  cytophilic 
antibody  (13) at  37°C  but not at 4°C.  We  investigated the possibility that the loss of 
EA  rosetting  seen  with  monocytes  cultured  on  adherent  complexes  represented 
capping  of Fc receptors. 
MNL  suspensions were chilled to  2-4°C  on ice, then pipetted  onto substrates that 
contained  fibrin with or without associated complexes. They were allowed to settle for 
2  h  at  4°C,  and  then  were  washed  and  incubated  with  EA  at  4°C.  Afterward,  the 
plates  were  kept  on  ice  until  read  (<10  min).  Monocytes  adhered  poorly  to  plain 
fibrin when  they settled at 4°C,  but  monolayers  formed  at  37°C  and  then chilled to 
4°C  had  the  same  rosetting  activity  (88%)  as  monolayers  kept  at  25°C  (87%). 
Monocytes  adhered  well  to  surface-bound  immune  complexes  at  4°C,  but  in  five 
experiments,  only  4  +  4%  formed  EA  rosettes.  The  percentage  of monocytes  in  the 
MNL  adhering  to the substrate at 4°C  was not changed, as determined  by peroxidase 
staining. C.  G.  RAGSDALE  AND W.  P.  AREND 
TABLE IV 
Effect of Colchicine, Cytochalasin B, and Propranolol on EA Rosette Formation* 
37 
Drug (conc.)~ 
Percentage of cells forming EA 
rosettes§ 
Substrate without  Substrate with 
adherent corn-  adherent  com- 
plexes  plexes 
None  87 :t: 10  9 +  7 
Cytochalasin B (0.02 mM)  34 _  4  3 _  4 
Colchicine (0. t mM)  58 +  17  1 +  1 
Cytochalasin B (0.02 mM) + Colchicine (0.1 mM)  87 -  7  2 +  1 
D-L-Propranolol (0.1 mM)  61 _  15  2 -- 4 
(0.2 mM)  28  0 
* MNL were incubated with drugs at the indicated concentrations,  then  monolayers were prepared on 
fibrin substrates with or without adherent complexes. 
:~ MNL were preincubated for 2 h with colchicine or cytochalasin B and for 5 min with propranolol before 
application to the plates. Conc., concentration. 
§ Results are expressed as the mean percentage of EA rosettes +  1 SD of four plates from two experiments. 
Colchicine  and  cytochalasin  B  each  reduced  Fc  receptor  activity  of monocytes 
cultured on plain fibrin when preincubated 2 h  separately with MNL, but not when 
preincubated together (Table IV). Incubation of cells with these drugs separately or 
together before addition to substrates inhibited spreading, but did not alter loss of the 
rosetting activity seen with monocytes cultured on surface-bound complexes (Table 
IV). In some experiments, MNL  were preincubated for 2  h  with either colchicine or 
cytochalasin B or both drugs at 37°C and then were applied to substrates at 4°C.  EA 
rosetting  was  also  performed  at  4°C  and  the  same  loss  of Fc  receptors  still  was 
observed (data not shown). 
The local anesthetic propranolol has been reported to inhibit capping of membrane 
immunoglobulin by lymphocytes (14). This drug reduced EA rosetting of monocytes 
on  plain  fibrin  without  altering  the  loss  of EA  rosetting  seen  with  monocytes  on 
complexes (Table IV). We concluded that  the loss of EA rosetting activity observed 
with cells incubated on surface-bound immune complexes did not represent capping 
or cytoskeletal modification of Fc receptors. 
Neither colchicine, cytochalasin B, nor propranolol affected C3 receptor activity of 
monocytes cultured on either substrate. 
Investigation  of the Role of Lysosomal  Proteases, Oxygen Radicals,  or Membrane  Perturbation 
in the Loss of Fc Receptors.  Monocytes cultured  on  surface-bound  immune  complexes 
manifest  extensive  spreading  (2),  lysosomal enzyme  release  (4),  and  generation  of 
superoxide  anion  and  chemiluminescence  (3).  We  investigated  the  possibility that 
lysosomal proteases or products of oxygen metabolism were damaging Fc receptors. 
Monocytes settling onto substrates that contain high amounts of HSA exhibit the 
same  secretion  of granule  enzymes  that  is  seen  when  monocytes  are  cultured  on 
substrates that contain immune complexes (4). When 200 ttg of liSA was incorporated 
into substrates of ~25I-fibrin, the same degree of lysosomal enzyme activity was elicited 
by  the  antigen  in  the  absence  of  added  antibody  (data  not  shown).  However, 
incubation of monocytes on substrates incorporating 200/xg HSA did not reduce Fc 
receptor activity (87% rosettes). 38  Fc RECEPTOR  ACTIVITY OF HUMAN  MONOCYTES 
TABLE g 
Effect of Oxygen Radicals, Local Anesthetics, and Indomethacin on Monocyte Fc Receptor Activity 
Treatment of cells (conc.)* 
Percentage of cells forming EA rosettes 
Substrate without  Substrate with ad- 
adherent  complexes  herent complexes 
None  87+  10  9+- 7 
Catalase (60 ~g/ml)  87  6 
SOD (1/~g/ml)  79  8 
Catalase (60 ~g/ml) + SOD (1 ~g/ml)  88  16 
Xanthine oxidase  89 
+ Acetaldehyde (4 mM)  75 
+ Acetaldehyde (10 mM)  54 
+ Acetaldehyde (20 mM)  92 
Ethanol  (300 mM)  90  10 
Oetanol (0.5 mM)  89  4 
Lidocaine (4 raM)  94  6 
Indomethacin  (0.1 ~M)  84  4 
(1/~M)  90  7 
(10/~M)  90  8 
(0.2 mM)  85  22 
DFP (1 mM)  99  11 
* Catalase, SOD, local anesthetics, and DFP were added to MNL suspensions  just before addition to plates. 
The cell suspensions were preincubated in indomethacin for 30 min before formation of the monolayers. 
Xanthine oxidase and acetaldehyde were added to monocyte monolayers that were further incubated for 
1 h before determination of EA rosetting. Cone., concentration. 
SOD  and  catalase  reduce  levels  of  superoxide  anion  and  hydrogen  peroxide. 
Incubation  of  MNL  with  these  enzymes  during  interaction  with  surface-bound 
immune complexes did not affect the loss of Fc rosettes (Table V). The extracellular 
generation  of 02-  and  H202  by  xanthine  oxidase  and  acetaldehyde also  did  not 
reduce Fc receptor activity of the cells on plain fibrin (Table V). 
Local anesthetics reduce  membrane  excitation  (15),  prevent  spreading of macro- 
phages  (5),  inhibit  immune-complex-stimulated  release  of  lysosomal  enzymes  by 
monocytes (C. G. Ragsdale and W. P. Arend. Manuscript in preparation.), and reduce 
superoxide  anion  generation  by  stimulated  macrophages  and  neutrophils  (6,  7). 
Incubation of MNL  with the neutral anesthetics ethanol (300 mM)  and octanol (0.5 
mM)  or  with  the  cationic  anesthetic  lidocaine  (4  mM)  did  not  change  receptor 
activity,  expressed  either  in  the  absence  or  presence  of  surface-bound  immune 
complexes (Table V). Indomethacin (0.1/.tM-0.2 mM) or di-isopropylfluorophosphate 
(DFP)  (1 mM)  did not affect Fc receptor activity of cells cultured on either substrate. 
Effect of 2dG and Cyclic Nucleotides  on Fc Receptor Activities.  We examined the effects of 
the glucose analogue 2dG on  Fc receptor activity of cells cultured on  fibrin with or 
without  adherent  immune  complexes.  2dG  inhibits  Fc-mediated  phagocytosis  by 
macrophages  and  exerts  this  effect  within  a  short  time  of  its  addition  to  cells 
independently of its effect on  ATP  levels (16).  2dG also inhibits lysosomal enzyme 
release  of monocytes  incubated  on  complexes  (C.  G.  Ragsdale  and  W.  P.  Arend. 
Manuscript  in  Preparation.).  When  100  mM  2dG  was  added  to  MNL  just  before 
addition to substrates, 85%  of cells incubated  on  plain fibrin and  9%  incubated  on 
adherent complexes formed rosettes. 
After prolonged incubation with 2dG, cellular ATP levels fall (16). One consequence C.  G.  RAGSDAI,E AND W.  P.  ARENI) 
TABLE VI 
Influence  o[ Cyclic Nucleotides  on Monocyte Fc Receptor Activity 
39 
Drug (cone.)* 
Percentage of cells forming EA 
rosettes~ 
0/zg Anti-  0.5 ktg Anti- 
body/plate  body/plate 
None  79 _+ 7  23 *- 14 
2dG (100 mM)  94 ± 4  80 ± 9 
ATP(1 mM)  56±9  9±8 
ATP (1 mM) + 2dG (100 mM)  88 ± 3  23 ±  12 
8 Br-cAMP (1 raM) + MIBX (0.05 mM)  52 ± 20  15 + 6 
8 Br-cAMP (1 mM) + MIBX (0.05 mM) + 2dG (100 mM)  83 ±  10  41 ±  11 
* MNL were preincubated with the  drugs at  the indicated concentrations (conc.) for 3 h  before the 
formation of monolayers and determination of EA rosetting. 
Results are expressed as the mean percent EA rosettes ±  1 SD of four plates from two experiments. 
of this  fall  is  that  the  substrate  for  generation of cellular cAMP  is  reduced.  We 
examined the effects of 2dG, ATP, and 8 Br-cAMP on monocyte Fc receptor activity 
using plates sensitized with 0.5/~g of antibody. MNL were preincubated in suspension 
for 3 h  with no drugs or with  100 mM 2dG,  1 mM ATP with or without 2dG, or  1 
mM 8  Br-cAMP and 0.05  mM MIBX with or without 2dG. When monocytes were 
preincubated in DME-LH, 79% formed EA rosettes on plain fibrin, and 23% formed 
rosettes on plates that contained 0.5/.tg of antibody in immune complexes (Table VI). 
After  preincubation  in  2dG,  94%  of cells  on  fibrin  formed  rosettes,  but  the  EA 
rosetting of cells cultured on adherent complexes was no longer reduced, as 80% of 
the cells formed rosettes. That the maintenance of Fc receptor activity seen with 2dG 
was mediated by cAMP reduction was supported by the fact that ATP or 8 Br-cAMP 
with MIBX partially reversed the 2dG effect when cells were cultured on complexes. 
ATP or 8  Br-cAMP with MIBX also reduced EA rosetting by cells on plain fibrin 
(Table VI). No significant reduction in EA rosetting of monocytes on fibrin was seen 
with  either 8  Br-cAMP or  the  phosphodiesterase  inhibitor MIBX  alone  (data  not 
shown). 
2dG also prevented the immune-complex-induced  loss of Fc receptor activity when 
plates contained 2 ~g of antibody (60% formed rosettes). The effect of 2dG could be 
reversed  if 2dG-treated  monolayers were  washed  and  incubated a  further  3  h  in 
DME-LH  (data  not  shown).  These  results  suggested  that  the  loss  of Fc  receptors 
induced by culture of monocytes on surface-bound complexes was mediated by the 
generation of cAMP within the cells. Similar preincubation of MNL with 8 Br-cGMP 
did not affect rosetting activity on any substrate. 
Discussion 
We  have  confirmed  that  EA  rosetting  activity  of human  monocytes  is  greatly 
reduced when the cells are cultured on surface-bound complexes. C3 receptor activity 
is not reduced when the substrate contains immune complexes with or without added 
C3. Our results suggest that the cells exhibit a selective loss of Fc receptor number or 
function and that this loss is mediated by cyclic nucleotides. 
Human monocytes respond differently than unstimulated mouse peritoneal mac- 
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Surface-bound  immune  complexes  caused  a  selective  loss  of EA  phagocytosis  by 
murine macrophages, but EA adherence was maintained (8). The density of antibody 
on  the  culture  surface was  not  known,  but  it  is  unlikely  that  differences observed 
between monocytes and  mouse macrophages resulted from different degrees of sub- 
strate sensitization. By using substrates with a density of antibody as low as 0.03/tg/ 
cm  2 we were unable to find a point where EA phagocytosis by human monocytes was 
selectively affected; instead,  EA rosetting and phagocytosis were reduced in parallel 
as antibody density increased.  In contrast,  when  rabbit alveolar macrophages were 
plated onto substrates that contained standard amounts of antibody (2 #g), there was 
some loss of EA adherence, but phagocytosis was sharply reduced. Substrates with  10 
times  as  much  antibody  caused  more  reduction  in  EA  rosetting  of  the  rabbit 
macrophages.  Perhaps  the  different  responses  of human  monocytes and  mouse  or 
rabbit macrophages to surface-bound immune complexes can be attributed to quan- 
titative  or  qualitative  variations  in  Fc  receptors  or  to  alteration  in  cell  function 
induced  by activation  or  differentiation.  Heavily activated  rabbit  alveolar macro- 
phages possessed more Fc receptors than did lightly stimulated macrophages, although 
the avidity of binding of monomeric IgG was the same (17).  Guinea pig peritoneal 
macrophages harvested from sterile oil exudates exhibited higher Fc receptor activity 
than did unstimutated  macrophages (18).  Two populations of Fc receptors binding 
monomeric immunoglobulin have been identified on murine macrophages (19). These 
aspects of Fc receptors have not been studied with human monocytes but differences 
may exist between these cells and animal macrophages. 
The decrease in EA rosette activity of human monocytes cultured on surface-bound 
complexes was concluded to be a  result of loss of Fc receptor function. This loss was 
not  caused  by inhibition  from solubilized  complexes or from the  release of soluble 
substances from the adherent  cells.  Furthermore, the loss of EA rosetting was not  a 
result  of migration  or capping of Fc receptors.  We found  that  monocytes on plain 
fibrin normally formed rosettes at 4°C and that the loss of Fc receptors seen with cells 
on  complexes still  occurred  at  4°C.  The finding  of normal  Fc receptor function  at 
4°C differs from that of others (20)  and possibly is a  result of differences in rosetting 
techniques.  Human monocytes do not  cap EA at  4°C,  whereas they cap readily at 
37°C  (12).  Propranolol, which inhibits capping of lymphocyte surface immunoglob- 
ulin,  also  did  not  prevent  the  loss  of EA  rosetting  with  monocytes on  complexes. 
Movement of membrane proteins  is  mediated  by microtubules  and  microfilaments 
and is stimulated by external cross-linking of receptors by antibodies or ligands (21). 
Preincubation of MNL with colchicine or cytochalasin B, or with both drugs together, 
did not prevent the immune complex-induced loss of Fc receptors. Thus, the loss of 
EA  rosetting  activity  of MNL  on  immune  complexes  was  not  a  result  of lateral 
receptor  movement  or  interiorization  mediated  by  cytoskeletal  elements.  The  Fc 
receptors were under some cytoskeletal control, however, as colchicine or cytochalasin 
B reduced EA rosetting with MNL cultured on plain fibrin, as has been observed by 
others (22,  23). 
Monocyte  Fc  receptors  were  not  destroyed  by  lysosomal  enzymes  or  by  toxic 
products of oxygen metabolism when the cells were cultured on complexes. Fc receptor 
activity could  not  be reduced  by incubating  MNL with  substrates  that  contained 
high amounts of antigen, a surface-bound phagocytic stimulus that leads to the same 
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of superoxide anion and hydrogen peroxide by SOD and catalase did not prevent the 
loss of EA rosetting by monocytes incubated on complex-containing substrates. Also, 
the loss of Fc receptor activity could  not  be induced  by extracellular  generation of 
02- and H202 with xanthine oxidase and acetaldehyde. Local anesthetics that prevent 
both lysosomal protease release and generation of oxygen radicals did not  alter the 
effect of immune complexes on EA rosetting. 
The only treatments that modified the effect of adherent immune complexes on Fc 
receptor activity were those  that  changed  cellular levels of cAMP.  Pretreatment  of 
cells  with  2dG  prevented  the  loss  of EA  rosetting  when  MNL  were  cultured  on 
adherent complexes. This effect of 2dG was partially reversed with ATP or by 8 Br- 
cAMP and MIBX, which suggests that 2dG, by decreasing levels of ATP, reduced the 
amount of substrate available for generation of cAMP.  Reversal of the effect of 2dG 
by adding 8 Br-cAMP makes unlikely the sole participation of other ATP-dependent 
pathways in immune complex-induced alteration of EA rosetting. The effect of 2dG 
was  not  a  result  of a  loss of monocyte viability because  the effect was reversed  by 
removal  of 2dG  from  the  medium.  Both  ATP  and  8  Br-cAMP  with  MIBX  also 
reduced Fc receptor activity of rnonocytes on plain fibrin. 
Studies  from other laboratories have described  effects of cyclic nucleotides  on Fc 
receptor function  that  vary with the cell type studied  and experimental conditions. 
Zuckerman and Douglas (24)  found that Fc receptor activity of a  murine plasmacy- 
toma line was reduced by cholera toxin, but only by amounts 1,000 times higher than 
those that elevated cellular cAMP levels. In contrast, cholera toxin did not reduce Fc 
receptor activity of rabbit alveolar macrophages despite the increase in cAMP levels; 
EA rosetting was reduced 20-30% by aminophylline (24).  Measurement of total celt 
levels of cAMP, however, may not reflect nucleotide levels in critical parts of the cell 
such as the membrane. Rhodes (25) observed that incubation of guinea pig peritoneal 
macrophages with dibutyryl cAMP or MIBX blocked increases in Fc receptor activity 
that otherwise occurred during 3 d  of culture.  In contrast, some mutant clones of a 
murine rnacrophage-like cell line that  possessed Fc receptors but  lacked EA phago- 
cytosis  regained  this  ability  after  a  5-  to  10-h  incubation  with  8  Br-cAMP  (26). 
Enhancement  of phagocytosis  was  not  accompanied  by  increases  in  total  cellular 
cAMP.  These observations may not  be relevant to our findings with human  mono- 
cytes, however, as monocyte EA rosetting ability was lost within 30 rain of plating of 
cells onto surface-bound immune complexes. 
Adherent immune complexes have been reported to induce other changes in cellular 
function  that  may be mediated  by cAMP.  An  inhibition  of B-cell  mitogenesis by 
surface-bound  complexes  was  associated  with  an  elevation  of cAMP  levels  (27). 
Elevation  of cellular  cAMP  by  exogenous  addition  of dibutyryl  cAMP  also  was 
associated  with  reduced  macrophage  release  of 02-  upon  stimulation  by  surface- 
bound IgG aggregates (28)  and by a  reduction  in antibody-dependent cell-mediated 
cytotoxicity by MNL (29). 
Our studies have not revealed the complete sequence of events that result in loss of 
EA  rosetting  by  monocytes  incubated  on  surface-bound  immune  complexes.  We 
hypothesize that the interaction of monocytes with the adherent  complexes leads to 
an activation of adenylate cyclase with an elevation in cellular or membrane cAMP 
levels, which,  in  turn,  mediate changes  in  Fc receptor number or function.  Prosta- 
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affect EA rosetting activity. Drugs inhibiting monocyte spreading (local anesthetics, 
colchicine, and cytochalasin B) did not prevent immune complex-induced loss of EA 
rosetting,  which  suggests  that  total  membrane  contact  with  the  ligand  was  not 
required. 
An  alteration  in  Fc  receptor  activity  initiated  by  an  elevation  in  cellular  or 
membrane  cAMP  might  occur  in  two  ways.  Once  generated  in  the  cell,  cAMP 
activates protein  kinases that  may, in  turn,  mediate phosphorylation of membrane 
proteins. Thus, the glycoprotein Fc receptor might be altered by direct phosphoryla- 
tion.  Alternatively,  protein  kinases  may  mediate  activation  of phospholipases.  Fc 
receptor  function  has  been  shown  to  be  destroyed  by treatment  of intact  cells  or 
isolated  receptors with  phospholipases  (30,  31).  cAMP-activated  lipases  have been 
described  in  adipose  tissue,  and  increased  lipolysis  has  correlated  better  with  the 
degree of protein phosphorylation  than with cAMP levels  (32).  Phospholipases also 
have been  detected  in  rabbit  alveolar macrophages  (33)  and  in  human  neutrophil 
granules  (34),  but  in  neither  instance  has  activation  by cAMP  been  examined.  In 
addition, phospholipase activity has been implicated in the alterations of membrane 
lipids  induced  by  phagocytosis  (35)  and  in  the  release  of arachadonic  acid  from 
mitogen-stimulated  lymphocytes  (36).  Indomethacin  has  been  reported  to  inhibit 
isolated cAMP-dependent  protein kinases of ileal mucosa (37),  but  its effect on the 
protein kinases of intact cells and other tissues is not known. 
The  results  of our  studies  may  have  some  relevance  to  human  diseases  where 
monocytes and  macrophages come  into  contact  with  surface-bound  immune corn- 
plexes, as in rheumatoid arthritis  (38)  or in some varieties of glomerulonephritis  (39, 
40).  We  have observed  that  the  in  vitro  loss  of Fc  receptor  activity of monocytes 
cultured on complexes persisted for at least 21 h. Such a loss of Fc receptor activity of 
monocytes or macrophages in vivo could lead to an impairment in immune clearance 
or in other protective cellular functions. 
Summary 
Human monocytes cultured on surface-bound immune complexes exhibited a  loss 
of ability to form rosettes with IgG-sensitized sheep erythrocytes (EA). This loss was 
not  a  result of inhibition  of Fc receptors by solubilized complexes nor of release of 
soluble  factors by the  cells.  Loss of EA  rosetting  was  not  prevented  by culture  of 
monocytes at 4°C, or by treatment with colchicine, cytochalasin B, or local anesthetic 
agents.  These  results  suggested  that  the  loss  was  not  secondary  to  capping  or 
interiorization  of Fc  receptors.  The  results  of other  studies  indicated  that  the  Fc 
receptors were not damaged by lysosomal enzymes or oxygen radicals.  Maintenance 
of EA rosetting ability of monocytes cultured  on surface-bound immune complexes 
was seen after a 3-h preincubation of the cells in  100 mM 2-deoxy-D-glucose (2dG). A 
similar preincubation  in  ATP or in  8-bromoadenosine  3':5'-cyclic monophosphoric 
acid  plus  the phosphodiesterase  inhibitor  methyl  isobutyl  xanthine  led  to a  partial 
loss of EA rosetting of cells on plain fibrin and to a  partial reversal of the effects of 
2dG seen with cells on complexes. 
We conclude that  EA rosetting of monocytes cultured  on surface-bound immune 
complexes is reduced by cyclic nucleotide-mediated effects on Fc receptor number or 
function. 
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